Universal Biosensors, Inc. Share Price

Equities

UBI

AU000000UBI2

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 11:20:07 26/04/2024 am IST 5-day change 1st Jan Change
0.15 AUD -11.76% Intraday chart for Universal Biosensors, Inc. -9.09% -25.00%

Financials

Sales 2022 4.52M 2.96M 246M Sales 2023 6.63M 4.33M 361M Capitalization 42.47M 27.74M 2.31B
Net income 2022 -26M -16.98M -1.42B Net income 2023 -6M -3.92M -327M EV / Sales 2022 5.86 x
Net cash position 2022 21.15M 13.81M 1.15B Net cash position 2023 5.27M 3.44M 287M EV / Sales 2023 5.61 x
P/E ratio 2022
-1.67 x
P/E ratio 2023
-6.3 x
Employees 80
Yield 2022 *
-
Yield 2023
-
Free-Float 47.82%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Universal Biosensors, Inc.

1 day-11.76%
1 week-9.09%
Current month-25.00%
1 month-21.05%
3 months-25.00%
6 months-40.00%
Current year-25.00%
More quotes
1 week
0.15
Extreme 0.15
0.17
1 month
0.15
Extreme 0.15
0.21
Current year
0.14
Extreme 0.135
0.30
1 year
0.14
Extreme 0.135
0.32
3 years
0.14
Extreme 0.135
1.04
5 years
0.13
Extreme 0.13
1.04
10 years
0.13
Extreme 0.13
1.04
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 06/20/06
Director of Finance/CFO 55 01/06/01
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member 58 30/16/30
Director/Board Member 68 12/15/12
Director/Board Member 64 02/16/02
More insiders
Date Price Change Volume
26/24/26 0.15 -11.76% 9,553,691
23/24/23 0.17 +3.03% 73,977
22/24/22 0.165 0.00% 78,614
19/24/19 0.165 0.00% 12,362
18/24/18 0.165 -5.71% 39,134

Delayed Quote Australian S.E., April 26, 2024 at 11:20 am IST

More quotes
Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, women’s health and fertility, non-human and environmental testing using its platform technology and hand-held point-of-use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates an electrochemical sensing system using opposing electrodes that detect specific analytes in samples as small as a droplet. Its products include Sentia Wine Analyzer, Xprecia Prime Coagulation Analyzer, Hemostasis Reference Laboratory (HRL) and PETRACKR Veterinary Blood Glucose Monitoring System. HRL supports contract research organizations, central laboratories, early phase clinics, pharmaceutical/ biotechnology companies and academic researchers conducting clinical trials. HRL offers multiplex cytokine analysis on the MESO QuickPlex SQ 120MM technology platform.
Calendar
More about the company

Annual profits - Rate of surprise